Preview

User

Not a user? Register with this site Forgot your password?

Safety and Risk of Pharmacotherapy

Advanced search
Fullscreen

For citations:

Serebrova S.Yu., Evteev V.V., Demchenkova E.Yu., Zhuravleva M.V., Prokofiev A.B. Current Mesalazine Products: Differences in Enteric-Coated Dosage Forms and Pharmaceutical Risks of Clinical Efficacy Reduction (Review). Safety and Risk of Pharmacotherapy. 2024;12(4):367-379. (In Russ.) https://doi.org/10.30895/2312-7821-2024-12-4-367-379



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

Publisher: Scientific Centre for Expert Evaluation of Medicinal Products

 

Processing of personal data
Development and technical support
of the site is carried out by NEICON
(Elpub lab)